$NRXP “The 1st qtr. of 2026 was a pivotal one for NRx, as we advanced two lifesaving drugs towards FDA approval with the aim of initiating commercial pharmaceutical operations by the end of this year,” said Dr. J. Javitt,
@NRxPharma CEO/Chairman
@SCStocks
finance.yahoo.com/sectors/he…